[144] Enova International, Inc. SEC Filing
Rhea-AI Filing Summary
Form 144 notice for Enova International, Inc. (ENVA) reports a proposed sale of 2,965 common shares through Morgan Stanley Smith Barney LLC with an aggregate market value of $363,612.78. The shares represent part of the issuer's outstanding common stock of 25,012,613 shares and are scheduled for sale on 08/28/2025 on the NYSE. The shares were acquired as restricted stock from the issuer on 02/23/2019 and payment was recorded as Not Applicable. The filer states there were no securities sold in the past three months for the account to be sold. Certain filer identification fields (CIK/CCC and submission contact details) are not provided in the document.
Positive
- Complete transaction details provided: class, quantity, acquisition date, acquisition type, broker, planned sale date, and aggregate value are specified
- Broker identified for execution: Morgan Stanley Smith Barney LLC
- Explicit statement that no securities were sold in the past three months for the account
Negative
- Filer identification fields missing in the provided content (CIK/CCC and submission contact details not shown)
- No additional context about the filer or reason for sale is included in the supplied text
Insights
TL;DR: Routine Rule 144 notice showing a planned sale of restricted shares via a broker; disclosure appears to meet form requirements.
The filing specifies the class, quantity, acquisition date, acquisition type, broker, and planned trade date, which are the core elements required by Rule 144 notices. The absence of reported sales in the prior three months is explicitly stated, and the broker is identified as Morgan Stanley Smith Barney LLC. However, the filing lacks visible filer identification fields such as a CIK or full submission contact details in the provided content, which are typically included elsewhere on a filing record. Based solely on the provided text, this appears to be a routine, compliant disclosure of an intended insider/affiliate sale.
TL;DR: This is a standard notice of proposed sale; content is factual and limited to the transaction details without additional corporate context.
The document lists the specific lot of 2,965 restricted shares acquired on 02/23/2019, the planned sale date of 08/28/2025, and the market value $363,612.78, providing transparent transaction-level disclosure. The representation statement about lack of undisclosed material adverse information is included, as required. No other corporate events, changes in ownership aggregation, or sales history beyond the three-month statement are provided in the text supplied.